Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kangxin Pharmaceutical is a China-based pharmaceutical company that specializes in the development, manufacturing, and marketing of Traditional Chinese Medicine (TCM) and chemical drugs. Established in 1998 and headquartered in Beijing, the company has built a reputation for its focus on cardiovascular health, particularly through its proprietary 'Kangxin' brand of health supplements and lipid-lowering treatments. The firm operates state-of-the-art GMP-certified facilities and maintains a comprehensive sales network across mainland China. In addition to its core pharmaceutical business, the company is involved in the production of health-oriented consumer products aimed at immune support and general wellness. It is recognized as a High-Tech Enterprise in Beijing and continues to invest in the modernization of traditional medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kangxin Pharmaceutical.